GSK has enlisted the aid of basketball legend Magic Johnson to front an awareness campaign on the dangers of respiratory syncytial virus (RSV) as it prepares for an FDA de
The race to market for a next-generation meningococcal vaccine has gone up a gear once again, with GSK reporting phase 3 results in support of its five-in-one candidate, a
A patient death in a phase 1 trial of Mersana Therapeutics’ antibody-drug conjugate XMT-2056 has resulted in the FDA formally placing the study on clinical hold.<
An FDA advisory committee has voted that GSK’s respiratory syncytial virus vaccine (RSV) is effective and safe for use in older adults, the day after it
An FDA panel of experts has recommended approval of Pfizer’s respiratory syncytial virus (RSV) vaccine in a pair of votes, neither of which was a resounding win.
The US FDA announced late last week that GSK's Jemperli (dostarlimab-gxly) has received regular approval for adult patients with dMMR recurrent or advanced endometrial cancer.